241 related articles for article (PubMed ID: 29117265)
1. Genomic sequencing identifies a few mutations driving the independent origin of primary liver tumors in a chronic hepatitis murine model.
Yang Z; Jia M; Liu G; Hao H; Chen L; Li G; Liu S; Li Y; Wu CI; Lu X; Wang S
PLoS One; 2017; 12(11):e0187551. PubMed ID: 29117265
[TBL] [Abstract][Full Text] [Related]
2. Whole genome sequencing of matched tumor, adjacent non-tumor tissues and corresponding normal blood samples of hepatocellular carcinoma patients revealed dynamic changes of the mutations profiles during hepatocarcinogenesis.
Mao R; Liu J; Liu G; Jin S; Xue Q; Ma L; Fu Y; Zhao N; Xing J; Li L; Qiu Y; Lin B
Oncotarget; 2017 Apr; 8(16):26185-26199. PubMed ID: 28412734
[TBL] [Abstract][Full Text] [Related]
3. Variable Intra-Tumor Genomic Heterogeneity of Multiple Lesions in Patients With Hepatocellular Carcinoma.
Xue R; Li R; Guo H; Guo L; Su Z; Ni X; Qi L; Zhang T; Li Q; Zhang Z; Xie XS; Bai F; Zhang N
Gastroenterology; 2016 Apr; 150(4):998-1008. PubMed ID: 26752112
[TBL] [Abstract][Full Text] [Related]
4. Exome capture sequencing reveals new insights into hepatitis B virus-induced hepatocellular carcinoma at the early stage of tumorigenesis.
Chen Y; Wang L; Xu H; Liu X; Zhao Y
Oncol Rep; 2013 Oct; 30(4):1906-12. PubMed ID: 23912677
[TBL] [Abstract][Full Text] [Related]
5. Cell Culture System for Analysis of Genetic Heterogeneity Within Hepatocellular Carcinomas and Response to Pharmacologic Agents.
Gao Q; Wang ZC; Duan M; Lin YH; Zhou XY; Worthley DL; Wang XY; Niu G; Xia Y; Deng M; Liu LZ; Shi JY; Yang LX; Zhang S; Ding ZB; Zhou J; Liang CM; Cao Y; Xiong L; Xi R; Shi YY; Fan J
Gastroenterology; 2017 Jan; 152(1):232-242.e4. PubMed ID: 27639803
[TBL] [Abstract][Full Text] [Related]
6. Applications of next-generation sequencing analysis for the detection of hepatocellular carcinoma-associated hepatitis B virus mutations.
Wu IC; Liu WC; Chang TT
J Biomed Sci; 2018 Jun; 25(1):51. PubMed ID: 29859540
[TBL] [Abstract][Full Text] [Related]
7. Inferring the progression of multifocal liver cancer from spatial and temporal genomic heterogeneity.
Shi JY; Xing Q; Duan M; Wang ZC; Yang LX; Zhao YJ; Wang XY; Liu Y; Deng M; Ding ZB; Ke AW; Zhou J; Fan J; Cao Y; Wang J; Xi R; Gao Q
Oncotarget; 2016 Jan; 7(3):2867-77. PubMed ID: 26672766
[TBL] [Abstract][Full Text] [Related]
8. Whole-genome sequencing of matched primary and metastatic hepatocellular carcinomas.
Ouyang L; Lee J; Park CK; Mao M; Shi Y; Gong Z; Zheng H; Li Y; Zhao Y; Wang G; Fu H; Kim J; Lim HY
BMC Med Genomics; 2014 Jan; 7():2. PubMed ID: 24405831
[TBL] [Abstract][Full Text] [Related]
9. Leptin receptor somatic mutations are frequent in HCV-infected cirrhotic liver and associated with hepatocellular carcinoma.
Ikeda A; Shimizu T; Matsumoto Y; Fujii Y; Eso Y; Inuzuka T; Mizuguchi A; Shimizu K; Hatano E; Uemoto S; Chiba T; Marusawa H
Gastroenterology; 2014 Jan; 146(1):222-32.e35. PubMed ID: 24055508
[TBL] [Abstract][Full Text] [Related]
10. Diverse modes of genomic alteration in hepatocellular carcinoma.
Jhunjhunwala S; Jiang Z; Stawiski EW; Gnad F; Liu J; Mayba O; Du P; Diao J; Johnson S; Wong KF; Gao Z; Li Y; Wu TD; Kapadia SB; Modrusan Z; French DM; Luk JM; Seshagiri S; Zhang Z
Genome Biol; 2014 Aug; 15(8):436. PubMed ID: 25159915
[TBL] [Abstract][Full Text] [Related]
11. Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity.
Moeini A; Sia D; Zhang Z; Camprecios G; Stueck A; Dong H; Montal R; Torrens L; Martinez-Quetglas I; Fiel MI; Hao K; Villanueva A; Thung SN; Schwartz ME; Llovet JM
J Hepatol; 2017 May; 66(5):952-961. PubMed ID: 28126467
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive genome sequencing of the liver cancer genome.
Nakagawa H; Shibata T
Cancer Lett; 2013 Nov; 340(2):234-40. PubMed ID: 23142287
[TBL] [Abstract][Full Text] [Related]
13. Next generation sequencing reveals genetic landscape of hepatocellular carcinomas.
Li S; Mao M
Cancer Lett; 2013 Nov; 340(2):247-53. PubMed ID: 23063663
[TBL] [Abstract][Full Text] [Related]
14. Multi-omics Analysis of Primary Cell Culture Models Reveals Genetic and Epigenetic Basis of Intratumoral Phenotypic Diversity.
Liu S; Yang Z; Li G; Li C; Luo Y; Gong Q; Wu X; Li T; Zhang Z; Xing B; Xu X; Lu X
Genomics Proteomics Bioinformatics; 2019 Dec; 17(6):576-589. PubMed ID: 32205176
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus pre-S2 mutant large surface protein inhibits DNA double-strand break repair and leads to genome instability in hepatocarcinogenesis.
Hsieh YH; Chang YY; Su IJ; Yen CJ; Liu YR; Liu RJ; Hsieh WC; Tsai HW; Wang LH; Huang W
J Pathol; 2015 Jul; 236(3):337-47. PubMed ID: 25775999
[TBL] [Abstract][Full Text] [Related]
16. Multiregional whole-genome sequencing of hepatocellular carcinoma with nodule-in-nodule appearance reveals stepwise cancer evolution.
Takeda H; Takai A; Kumagai K; Iguchi E; Arasawa S; Eso Y; Shimizu T; Ueda Y; Taura K; Uemoto S; Kita R; Haga H; Marusawa H; Fujimoto A; Seno H
J Pathol; 2020 Dec; 252(4):398-410. PubMed ID: 32815153
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Targeted Sequencing Panel for Hepatocellular Carcinoma Genomic Screening.
Paradiso V; Garofoli A; Tosti N; Lanzafame M; Perrina V; Quagliata L; Matter MS; Wieland S; Heim MH; Piscuoglio S; Ng CKY; Terracciano LM
J Mol Diagn; 2018 Nov; 20(6):836-848. PubMed ID: 30142445
[TBL] [Abstract][Full Text] [Related]
18. Leveraging a Multi-Omics Strategy for Prioritizing Personalized Candidate Mutation-Driver Genes: A Proof-of-Concept Study.
Ding K; Wu S; Ying W; Pan Q; Li X; Zhao D; Li X; Zhao Q; Zhu Y; Ren H; Qian X
Sci Rep; 2015 Dec; 5():17564. PubMed ID: 26631547
[TBL] [Abstract][Full Text] [Related]
19. Specific genomic and transcriptomic aberrations in tumors induced by partial hepatectomy of a chronically inflamed murine liver.
Ella E; Heim D; Stoyanov E; Harari-Steinfeld R; Steinfeld I; Pappo O; Perlman TS; Nachmansson N; Rivkin L; Olam D; Abramovitch R; Wege H; Galun E; Goldenberg D
Oncotarget; 2014 Nov; 5(21):10318-31. PubMed ID: 25401338
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic mutations and dysregulated pathways in obesity-associated hepatocellular carcinoma.
Shen J; Tsoi H; Liang Q; Chu ES; Liu D; Yu AC; Chan TF; Li X; Sung JJ; Wong VW; Yu J
Oncogene; 2016 Dec; 35(49):6271-6280. PubMed ID: 27132506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]